IN THIS LECTURE I shall attempt to survey
the current important problems in the commonest forms of cardiomyopathies and suggest avenues along which research may profitably proceed in the future.
The classification of the cardiomyopathies into hypertrophic, congestive, obliterative, and restrictive has the advantage of allowing a study in depth to be made of the pathological, functional, and clinical features of these types without prior knowledge of their etiology. The classification also assists the identification of various forms of cardiomyopathy in circumstances where causal factors are being sought.' Figure 1 shows the four types in diagrammatic The restrictive type is characterized by stiff muscle without marked hypertrophy, as in amyloid disease.
Hypertrophic Cardiomyopathy
The pathology of this condition is now well recognized and the characteristic lesion is grossly hypertrophied, short, thick, fragmented muscle fibers concentrated in circular arrangements, or whorls, with large nuclei and perinuclear spaces. The abnormal myocardial fibers may be interrupted by fibrous tissue which arises within the myocardial fibers and spreads toward the surface, replacing a variable amount of muscle tissue, which results in shortening of the fiber and its termination in collagen tissue. 4 In the original observations of our group4 many instances of irregular cellular contraction, with some Circulation, Volinel( .5( utgtst 1.974 sarcomeres contracted and others relaxed in the cell, were found, but the possibility of an artifact being responsible was not excluded. Ferrans, Morrow, and Roberts5 observed a number of abnormalities of myofibrillar structure, localized in the Z bands, consisting of widening and spreading of the Z band material toward the center of the sarcomere, splitting of Z bands and attachment of Z bands to the sarcolemma, with increased amounts of material similar to that of the Z bands at points of attachment of myofibrils to intercellular junctions. Their description was in agreement with previous observations, and they also noted alterations in myofibrillar orientations which were considered unique to IHSS. Both branched and unbranched cells contained areas with obliquely or transversely oriented myofibrils. The pattern of myofibrillar organization ranged from entirely normal in some cells to severe disarray in others with immediately adjacent myofibrils orientated perpendicular to each other. In Figure 4 shows the effect of practolol on the relationship of left ventricular stroke work index and left ventricular ejection time index in seven patients with hypertrophic cardiomyopathy and in five control patients. It can be seen that in all but two of the patients with hyp-rtrophic cardiomyopathy the left ventricular stroke work index is increased, despite the increase in ejection time, indicating that practolol permits better ventricular filling. Figure 5 shows diagrammatically the more favorable diastolic pressure-volume relationships in hypertrophic cardiomyopathy after beta-adrenergic blockade and the unfavorable influence of betaadrenergic stimulation.
These results encouraged us to carry out a trial of beta-adrenergic blocking agents on the symptoms and signs of hypertrophic obstructive cardiomyopathy. A double-blind trial was carried out using a placebo, practolol, and propranolol.'O Three hundred twenty milligrams propranolol daily, 800 mg practolol daily, and a placebo were administered in four week periods in a double-blind manner to 16 patients. The symptoms were assessed using a diary card and a scoring method. Clinical examination, phonocar and apex cardiography were carried out. indicated that dyspnea was improved only with severe limitation, but angina becam quent with both beta-adrenergic blockii though more strikingly with propranolol. Ti tricular ejection time index was si} prolonged with propranolol but not with Both drugs significantly reduced the "A" v apex cardiogram and the isovolumic relax-
The results suggested improved ventrict sibility. Though the possibility that the re the size of the "A" wave might have be reduction of atrial drive has to be consider of the results in acute observations, it se likely that long term oral beta-adrenergii agents do improve ventricular distensibilit
The Relationship of Catecholamine Disorder to Hypertrophic Cardiomyopathy
It is now relevant to examine the evid neural crest origin or catecholamine abnc hypertrophic cardiomyopathy. There are a features which suggest that there may be nection. First, there is the association wit hypertension, which, although rare, was de Brock who first recognized the disease at 1957." Second, there is the finding by Ever of excessive noradrenosis in the left ventr 3-stimulat HOI PRESSURE VOLUME Figure 5 The effect of pharmacological interventions on pre relationships in hypertrophic obstructive car (HOCM). Beta-adrenergic blockade increases diastoli reduces diastolic pressure while beta-adrenergic sti creases pressure and reduces volume. The The first description by Brock of what we now recognize as hypertrophic obstructive cardiomyopathy was related to a patient with severe systemic hypertension, and he regarded the muscular hypertrophy of the outflow tract of the left ventricle that produced the obstruction as being secondary to the hypertension." Since then, speculation that either excessive afterload on the left ventricle or fixed outflow tract obstruction might produce hypertrophic cardiomyopathy has been rife. The demonstration of an inappropriate degree of hypertrophy with the clinical and hemodynamic characteristics of hypertrophic cardiomyopathy in association with a mild degree of fixed outflow tract obstruction in the form of valvar aortic stenosis or discrete subvalvar aortic stenosis has been noted in three patients in our experience. Apart from the association with fixed outflow tract obstruction of the left ventricle or systemic hypertension, hypertrophic obstructive cardiomyopathy has been described also in two other apparently unrelated conditions associated with severe cardiac hypertrophy. These are Friedreich's ataxia15 and Pompe's disease. 16 Although massive ventricular hypertrophy involving the septum and papillary muscles, with gross cardiomegaly is recognized in Pompe's disease, the histology is typical of glycogen storage disease with vacuolation of cardiac muscle cells due to glycogen infiltration, giving a typical lattice work appearance, but no evidence of the typical histological and electron microscopic appearances of hypertrophic cardiomyopathy.
A number of descriptions of massive hypertrophy and obstruction to ventricular outflow have been reported in patients with Friedreich's ataxia who have cardiac involvement. Outflow tract gradients on both sides of the heart are well recognized, and Thoren"5 has commented on the frequency of systolic murmurs, which tend to disappear as patients become older and therefore may not be recognized by cardiologists or neurologists dealing only with adult patients.
Angiocardiographic studies'7 18 have shown appearances very similar to those found in hypertrophic obstructive cardiomyopathy. A large body of pathological evidence is not available, but histological examination of 16 hearts by Hewer'9 showed considerable muscle hypertrophy with large and bizarre muscle fibers somewhat reminiscent of hypertrophic obstructive cardiomyopathy and often severe interstitial fibrosis. Evidence is so far not available on the distribution and orientation of the muscle fibers and on electron microscope studies. A striking difference, however, was the severe though not widespread narrowing of small coronary arteries, which was considered to be secondary to the cardiac muscle disease rather than a primary condition. This difference, together with the absence of any evidence of similar neuromuscular disease in patients with hypertrophic cardiomyopathy, or of the development of neuromuscular disease with age in the same condition, suggests that the two are probably separate disorders, in spite of interesting similarities. However, it is interesting to postulate a possible common factor in the form of excessive sympathetic discharge or inappropriate reaction of the heart muscle to normal sympathetic discharge.
The Natural History of Hypertrophic Cardiomyopathy
The natural history of hypertrophic cardiomyopathy is, I believe, largely determined by the stiffness of the left ventricle and the filling problems, and the clinical course tends to be related mainly to the level of the left ventricular end-diastolic pressure, particularly on effort. Most patients appear to have some degree of obstruction to left ventricular outflow tract, either persistently or on provocation, at some time during their lifetime, but there is no doubt that others in whom evidence of outflow tract obstruction disappears may develop severe heart failure, often associated with atrial fibrillation and embolism. This course of the disease however does not appear to occur in more than approximately 10% of patients.20
Our original study of the natural history revealed that most patients maintained a stable course, but that a minority of patients tended either progressively to deteriorate or to apparently improve symptomatically. Sudden death is a well recognized complication and in our experience appears to be slightly more probable in patients with a particularly high left ventricular enddiastolic pressure and a short history of symptoms of increasing severity. Studies by my colleague Dr. Oakley in our patients have suggested that the prognosis may be particularly unfavorable in children in whom there may be widespread disease and extensive generalized hypertrophy. Our study by Swann and others20 showed that symptoms and their deterioration were related to the level of left ventricular end-diastolic pressure, as might be expected. There was no relationship between either severity of symptoms or tendency to deterioration and the left ventricular systolic gradient, suggesting that this is a less important feature. A more recent study of our material2' based on 120 patients who were followed for an average of four and one half years revealed that familial or suspected familial disease was present in 39, the commonest mode of death being sudden, which occurred in 19 patients. Young males with a familial history seemed to be more prone to die suddenly than other patients. The estimated mortality was 15% at five years, and 35% at ten years, giving an annual mortality rate of 3.5% (fig. 6 ). The average age of onset of symptoms was 28 years and the average duration of symptoms before death was nine years. In many patients, however, deterioration was slow, though the development of atrial fibrillation was associated with a striking increase in symptoms. It is probable that the developmental myocardial abnormality is present from birth and that the detection of the murmur usually precedes symptoms ( fig. 7) . In this series it was noted that treatment with betaadrenergic blockade did not prevent sudden death, though most of the patients had been treated with doses that would now be regarded as less than optimal.'0 A multicenter study by Shah et al. 22 into the natural history of hypertrophic obstructive cardiomyopathy, which included much of our case material, was concerned with the course of 190 patients who had proven left ventricular outflow tract obstruction. This series excluded all patients without outflow tract obstruction, and thus, according to our views, would have excluded perhaps 10% of patients. The incidence of severe symptoms increased with each decade, being 9% for the first decade, and 70% for the sixth to eighth decades. Fifteen of 58 patients who underwent myotomy of the left ventricular outflow tract died at or after operation. Thirty-one of the remaining 172 patients died of the disease, giving a mortality of 18% for the 5.2 years of average follow-up and an annual mortality of 3.5%. This figure was identical to our findings2`in a series which included patients both with and without outflow tract obstruction. Twentysix of 31 deaths were sudden. Seven percent of the deaths were in patients who had been treated surgically; 18% of the patients dying were being treated with a beta blockade drug, and 16% without any treatment died. These figures would suggest a more favorable influence of surgical treatment on prognosis than that of beta-adrenergic blockade. It is possible that resection of the outflow tract muscle might in some way slow down the progress of the disease or diminish abnormal contraction and relaxation and thus the development of further hypertrophy. However, the figures cannot be taken entirely at face value since patients without outflow tract obstruction who may have had more serious disease were excluded from the series, giving a bias in favor of surgery.
Undoubtedly sudden death is the most important feature of the natural history in this disease as it can be totally unexpected and there are few clues as to its imminence. Sudden death is well recognized in NYHA CLASS The progressive disappearance of outflow tract obstruction appears to be associated with progressive advance of the disease. Thus the loss of the outflow tract obstructive murmur has been associated in our experience with progressive dyspnea and the development of heart failure.' It appears likely that in the earlier stages of the disease, and throughout the lifetime of many patients, systolic function of the left ventricle remains good though ill-coordinated. Damage to left ventricular muscle, by reducing contractile power, diminishes the force of left ventricular contraction and thus reduces the outflow tract obstruction. This was well documented in a patient whom I treated in whom the signs of outflow tract obstruction disappeared completely following a large antero-septal infarct produced by dissection of the left anterior descending coronary artery. In addition to the loss of signs of outflow tract obstruction, angina disappeared and the echocardiogram no longer showed the appearances of outflow tract obstruction.
In a recent report23 myocardium obtained at operation or necropsy from 20 patients (11 with obstructive and nine with nonobstructive disease) was studied by light and electron microscopy. All the muscle specimens showed the characteristic greatly hypertrophied, bizarrely-shaped, and abnormally oriented cardiac muscle cells in the septum. In patients who had obstruction these abnormalities were either absent or only rarely found in tissue from the left ventricular apex, posterior wall, or right ventricle. By contrast, many areas of abnormal cells were present in both the left ventricular free wall and right ventricle in seven of the nine patients without obstruction who were symptomatic. The authors concluded that the characteristic cellular abnormalities are always present in the septum but that the more extensive involvement of the free walls of ventricles is limited to patients without obstruction. These findings would certainly harmonize with our views that widespread disease with a poor prognosis may be found in the absence of any obstructive element. It seems likely that the pattern of the disease is determined largely by the extent, distribution, and progression of the specific myocardial lesions.
Progressive deterioration leading to heart failure is caused by a number of factors: notably, the reduced left ventricular filling time and increased left ventricular filling resistance, and tachycardia, which limits filling time, causes further increase in left ventricular end-diastolic pressure and may thus precipitate heart failure. The development of atrial fibrillation, with consequent loss of atrial drive, together with increasing hypertrophy and extension of the disease, completes the picture of deterioration leading to death in heart failure. It is likely also that these factors contribute to, or may be the cause of sudden death when sudden limitation of filling capacity causes a precipitous fall in cardiac output and coronary blood flow with consequent ventricular fibrillation.
Prospects and Predictions for Hypertrophic Cardiomyopathy
In the light of the known factors and numerous speculations, it is now appropriate to attempt to predict the paths of investigation that would be desirable for the further elucidation of this disease over the coming years.
First, a follow-up study of patients' relatives to determine the incidence of the disease and its patterns of progression would clearly be of great value. An increase in the ratio of thickness of ventricular septum to posterior wall in patients with hypertrophic cardiomyopathy has been demonstrated in a limited number of patients.24 If this initial study proves to have validity in larger numbers, then serial echocardiographic examinations would provide a useful, harmless, and subtle way of diagnosing presymptomatic stages of the disease and following its development in individual patients.
Second, serial examination of patients by noninvasive techniques such as echocardiography will be needed to determine the effect of long term betaadrenergic blockade on the incidence of sudden death. The persuasive evidence obtained by acute observations and the theoretical considerations involved suggest a beneficial role for beta-adrenergic blockade and indicated that further evaluation of the place of long-term, high dosage regimes is needed. Third, efforts should be directed to a study of the catecholamine content of the specific lesions in the myocardium in hypertrophic cardiomyopathy using new and refined techniques of fluorescent staining. Attempts should be made to determine whether conditions such as Pompe's disease and Friedreich's ataxia that produce clinical hemodynamic and gross morbid anatomical appearances similar to hypertrophic cardiomyopathy also show the characteristic myocardial ultrastructural lesions. Further studies of catecholamine function and production in conditions in which abnormality of catecholamine metabolism or response may be a common factor are needed.
Finally it should be possible to attempt to create an experimental model of the disease by determining the effect of abnormal orientations of developing cardiac Circulation. Voltinie 50. August 1974 muscle cells grown on tissue culture.
In my view it is unlikely that much further study of the exact dynamics of outflow tract obstruction and mitral regurgitation will yield significant additional basic information regarding the disease. The hemodynamics, clinical features, and prognosis have already been reasonably accurately delineated. Knowledge of the cause of the disease, its relationship to other cardiac and noncardiac conditions, and an effective method of treatment are urgently needed.
Congestive Cardiomyopathy I turn now to the enigma of congestive cardiomyopathy. This is a multifaceted syndrome characterized by isolated cardiomegaly with dilated ventricles, heart failure, and more extensive hypertrophy than would be expected from the degree of dilatation. It is likely that there are many causes and the definition covers not a single disease but a syndrome that is a final common path of many differing conditions that insult the ventricular myocardium.
Insults that deserve particular study are those of alcohol, pregnancy and the puerperium, systemic hypertension, and infections, probably of viral nature. These four phenomena may be regarded as "risk factors" if not actual causes, for it is probable that in many instances it is the combination of more than one factor that produces the devastating damage to the myocardium.
It is true that other myocardial diseases can produce the clinical and pathological final common path known as congestive cardiomyopathy. These are conditions such as endocardial fibroelastosis, Chagas' disease, and many infiltrative diseases of the myocardium or granulomatous disorders. There are also connective tissue disorders such as diffuse systemic sclerosis that may involve the myocardium.
I shall not consider alcohol further as it is well known that excessive amounts can produce a syndrome of severe congestive heart failure which is not infrequently fatal and which tends to improve when alcohol is discontinued and to recur when drinking is recommenced. It is likely, however, that some factor other than ingestion of alcohol is implicated since not every subject who takes large quantities of alcohol develops alcoholic cardiomyopathy. Probably individual differences and The failure to discover any characteristic features on ultrastructural studies or the myocardium in congestive cardiomyopathy suggests that the appearances may represent little more than a graveyard of dead tissue without revealing the cause of death and that ultrastructure studies are of only limited value. The investigation of the tombstones in a graveyard, however detailed, will not yield clues to the cause of death of the bodies beneath.
It therefore becomes necessary to look beyond the boundaries of structure and ultrastructure to the finer processes of myocardial chemistry and cellular biology. Studies of subcellular organelle enzymes and the functions of lysosomes, which, on being damaged, rupture and release enzymes that may digest cells, have been started at the Royal Postgraduate Medical School by my colleagues C. M. Oakley and T. Peters.
Prospects and Predictions for Congestive Cardiomyopathy
The problems are in many ways much greater than for hypertrophic cardiomyopathy because we are not dealing with a discrete disease entity but a multifactorial syndrome producing a final common path toward irreversible myocardial damage. The most fruitful approach is likely to come from improved techniques of cardiac biopsy that permit safe and repeated studies of myocardial function to be made, and from improved studies of cellular biology with examination of enzyme systems and search for viruses and their products.
It should be possible to create an animal model that satisfies the hemodynamic and clinical characteristics of congestive cardiomyopathy by the administration of such infective or toxic agents that might possibly be causally related in man.
Accurate long-term follow-up studies of cases of known acute myocarditis to detect chronic cardiac damage are essential.
Epidemiological studies of congestive cardiomyopathy should be undertaken to determine whether other factors, as yet unsuspected, may be involved. General agreement on the diagnostic criteria for congestive cardiomyopathy is vital and multicenter studies could be of great value, provided uniformity of case material and rigid criteria of diagnosis are insisted upon. Here the Scientific Council on Cardiomyopathies of the International Society of Cardiology might be of crucial importance.
At the present time the prognosis for severe congestive cardiomyopathy is so bleak and treatment so unsatisfactory that cardiac transplantation may be considered in desperate cases.
Conclusions
I have not attempted to be comprehensive and to cover all aspects of the cardiomyopathies. Rather, I have selected those aspects and features that I believe to be of major import and that require further study in the future and I have not hesitated to be provocative with hypothesis. As in so many areas of medicine, the study of the cardiomyopathies requires the integrated efforts of research workers in many disciplinesclinical, pathological, biochemical, virological, immunological, epidemiological, and possibly others not as yet considered. The intellectual challenge and stimulation provided by this fascinating and taunting group of diseases may be blunted by the emotional frustration arising from the unfortunate prognosis and the limitations of treatment. But nevertheless we should never lose our scientific curiosity, which has been compared to "that direct incontinence of the spirit which has a pleasure in it like wrestling with a fine woman.
